Clinical Trial Update: The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating whether vorinostat can induce HIV RNA expression in resting CD4+ T cells of HIV-infected individuals on stable ART. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV-1 Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-29